Materiality
85.25
Source
External coverage
Decided
2026-04-01
Biogen Buys Apellis for $5.6B to Expand Kidney Drugs
View event details5 more curated
Biogen Buys Apellis for $5.6B to Expand Kidney Drugs
We are still collecting relevant articles for BIIB. Curated events highlight the most material developments impacting this ticker right now.